You notice that one breast feels tighter than the other. Over time, the implant seems to sit higher, the shape looks less natural, or discomfort begins to interfere with sleep and movement. Many patients first assume the implant has shifted or that something must be seriously wrong. Often, the issue is capsular contracture, a tightening of scar tissue around a breast implant that requires a careful evaluation rather than a quick, one-size-fits-all fix.
How to fix capsular contracture depends on its severity, how many times it has returned, your implant and pocket, your tissue quality, and whether you've had radiation or previous breast operations. Mild cases may be observed or treated with selected non-surgical measures. Established or painful contracture often requires revision surgery, and the most durable plan frequently addresses the capsule, the implant, and the pocket together.
Table of Contents
- Recognizing Capsular Contracture and Why It Happens
- Understanding the Baker Grading System
- Conservative Measures for Early-Stage Contracture
- Surgical Revision Techniques for Capsular Contracture
- Advanced Adjuncts Including ADM and Mesh Support
- Perioperative Strategies to Reduce Recurrence Risk
- Recovery Expectations and Long-Term Follow-Up
Recognizing Capsular Contracture and Why It Happens
A patient may notice the change gradually. The breast initially feels slightly firmer, then becomes increasingly tight. The implant may look acceptable while the texture changes, or the breast may become visibly rounder, higher, or uneven. Some people have discomfort, while others mainly notice firmness and distortion.
After augmentation or reconstruction, the body naturally forms a capsule of scar tissue around the implant. That capsule normally remains thin and flexible. With capsular contracture, it thickens and tightens, placing pressure on the implant and changing the breast's feel or appearance. The process can affect one breast or both, and it can develop months or years after the original operation.
Factors that shape the evaluation
Contracture doesn't have one universal cause. Surgeons consider the patient's surgical history, possible infection or inflammation, implant characteristics, bleeding around the implant, tissue thickness, and whether radiation affected the breast. Radiation history deserves particular attention, because it can make the tissue less forgiving and influence decisions about pocket management and additional support.
A change in firmness doesn't automatically mean contracture. A new lump, swelling, sudden pain, redness, drainage, or a rapid change in shape needs prompt medical assessment because other implant or breast conditions can produce similar symptoms. Your surgeon may examine both breasts, review operative records, and recommend imaging when the physical findings or implant history make it appropriate.
The causes of capsular contracture matter because treatment should address the patient's risk profile, not just the visible tightness. A consultation with Dr. Thomas T. Jeneby, a board-certified plastic surgeon in San Antonio, Texas, can help determine whether observation, medical management, or revision surgery makes sense for your anatomy and goals.
Practical rule: A breast that becomes progressively firm, painful, elevated, or distorted deserves an examination. Waiting for severe symptoms can narrow the available options.
Understanding the Baker Grading System
The Baker grading system gives surgeons a shared language for describing how an implant feels and looks. It doesn't replace an examination, and patients shouldn't rely on self-assessment alone, but it helps explain why one person may be monitored while another is advised to consider revision.
Grade I and Grade II
Baker Grade I describes a breast that feels soft and looks natural. The capsule is present, as it normally is around an implant, but it doesn't create a clinically noticeable problem. No treatment is usually needed for contracture itself.
Baker Grade II means the breast feels somewhat firm, but its appearance remains generally normal. The implant may feel less natural to the patient or surgeon, yet there's no major visible distortion. Depending on the duration, symptoms, and examination, a surgeon may discuss observation, massage only when appropriate, compression, or selected medication-based treatment.
These grades can be easy to confuse. Some patients feel firmness because of thin soft-tissue coverage, implant position, or normal differences between breasts. A physical examination matters more than a label chosen from a mirror check.
Grade III and Grade IV
Baker Grade III involves firmness with an abnormal appearance. The breast may look overly round, sit higher, or appear distorted compared with the other side. At this point, conservative care may not provide a dependable correction, especially when the capsule has become thick or the shape has changed.
Baker Grade IV combines hardness, visible distortion, and pain or significant tenderness. Severe contracture usually calls for a surgical discussion because the capsule is mechanically affecting the implant and surrounding tissues. The procedure may involve releasing or removing some or all of the capsule, exchanging the implant, changing the pocket, and adding support when tissue quality or recurrence history justifies it.
During consultation, Dr. Jeneby evaluates firmness, implant position, symmetry, skin and breast tissue, scars, and the condition of the existing pocket. Imaging may be recommended when the implant's integrity, breast tissue, or a new symptom needs additional clarification. The grade helps organize the conversation, but it's only one part of the treatment decision.
Conservative Measures for Early-Stage Contracture
Non-surgical care has a legitimate but limited role. It's most reasonable when the breast is only mildly firm, the shape remains acceptable, symptoms are stable, and the examining surgeon believes the capsule hasn't progressed to a fixed mechanical problem. Conservative treatment shouldn't be presented as a reliable way to reverse every established contracture.
Massage is sometimes recommended to maintain mobility or address early tightness, but the technique and timing matter. Forceful manipulation can be inappropriate, particularly after revision surgery or when the implant, incision, or tissues need protection. Compression garments may also be considered in selected situations, although fit, pressure, and duration should come from the treating surgeon rather than an internet protocol.
Medication requires medical supervision
Medication-based approaches deserve a more nuanced discussion than “surgery is the only answer.” A 2025 systematic review and meta-analysis reported that leukotriene receptor antagonists, particularly zafirlukast, may reduce severity and recurrence, especially in early-stage disease. The findings don't make zafirlukast appropriate for every patient, and the medication has potential risks, interactions, and monitoring considerations that require a clinician's evaluation. Read the systematic review on medical and implant-surface approaches.
The practical comparison looks like this:
| Approach | Where it may fit | Limitation |
|---|---|---|
| Observation | Mild firmness with stable shape and minimal symptoms | It won't release a fixed, tight capsule |
| Surgeon-directed massage | Selected early cases or postoperative protocols | Incorrect pressure or timing can be harmful |
| Compression | Carefully chosen support during a defined phase | It doesn't remove scar tissue |
| Medication | Early-stage disease after medical screening | Evidence and suitability remain patient-specific |
| Revision surgery | Persistent pain, distortion, advanced firmness, or recurrence | Requires healing, planning, and acceptance of recurrence risk |
Conservative care has reached its limit when firmness progresses, the implant becomes visibly displaced, pain persists, or the breast remains abnormal despite an appropriate trial. Delaying a needed revision can allow scar tissue and pocket distortion to become more complex. A patient with early symptoms should seek evaluation, but shouldn't interpret “non-surgical” as “risk-free” or “permanent.”
Surgical Revision Techniques for Capsular Contracture
Surgery becomes the main option when a capsule causes persistent pain, visible distortion, implant displacement, or continued problems despite conservative care. The operation should match the capsule, implant, pocket, tissue quality, previous procedures, and the patient's preference to retain or replace the implant. A revision plan must address the mechanical conditions that produced the contracture, not only the scar tissue that is visible during surgery.
What each technique does
Capsulotomy releases a tight capsule through controlled incisions. It can create space when the capsule is relatively thin and complete removal would add unnecessary dissection. Because it leaves much of the scar tissue in place, release alone may not correct implant position or the factors contributing to recurrence.
Partial capsulectomy removes the most abnormal or constricting areas. Total capsulectomy removes the capsule more extensively when the entire capsule appears abnormal or the surgical findings support broader excision. The appropriate extent depends on anatomy, tissue quality, and operative findings. Removing more capsule is not automatically safer, particularly when dissection risks injury to thin overlying tissue.
The revision often combines capsule treatment with implant exchange and pocket conversion. The surgeon generally:
- Removes the existing implant.
- Releases or excises the capsule according to the findings.
- Converts the pocket if its location is contributing to malposition, tension, or recurrence.
- Places a new implant in the planned pocket, adding support when the tissue or recurrence history warrants it.
A 2024 systematic review reported recurrence ranges of 0% to 26% for procedures that generally included implant exchange and pocket conversion, compared with recurrence of up to 54% in approaches without exchange. Review the evidence on surgical management of capsular contracture. These findings vary across studies and should not be presented as an individual guarantee.
| Technique | Key considerations |
|---|---|
| Isolated capsulotomy or partial capsulectomy | May suit selected anatomy, but it may leave the implant, pocket, or residual scar-related forces unchanged |
| Capsulectomy without implant exchange | Removes scar tissue while leaving existing hardware in place, so an implant-related or pocket-related problem may persist |
| Open capsulotomy | Less extensive dissection, with recurrence influenced by patient selection and operative technique. reviewed evidence |
| Capsulectomy, implant exchange, and site change | Addresses the capsule, hardware, and pocket together when the current pocket is contributing to contracture or malposition |
The frequently described “gold standard” combination, capsulectomy plus implant exchange plus site change, had an estimated success rate of 79% in a 2023 review, while published recurrence across techniques ranged from 0% to 54%. Read the 2023 review of capsular contracture management. The practical limitation of capsulectomy alone is clear: it can remove scar tissue without correcting the implant surface, pocket location, tension, or tissue support.
A detailed breast implant revision surgery plan weighs those variables together. The goal is a pocket and implant arrangement that fits the patient's anatomy and lowers avoidable mechanical stress, while acknowledging that recurrence can still occur.
Advanced Adjuncts Including ADM and Mesh Support
Recurrent contracture changes the threshold for adding support. A patient with one mild episode may not need an advanced reinforcement material. Someone with repeated recurrence, thin tissue, bilateral disease, a failed prior revision, or radiation-related tissue changes may require a more protective strategy.
Acellular dermal matrix, or ADM, provides a biologic scaffold that can reinforce the pocket and reduce direct tension around the implant. In a classic comparative series summarized in later reviews, conventional treatment succeeded in 72.5% of first occurrences, 62.5% of second occurrences, and 50.0% of third occurrences. ADM-assisted treatment succeeded in 96.9% of cases in that series. Review the ADM evidence.
A selective algorithm can be more useful than placing ADM routinely. In the 2020 clinical series, ADM was used for higher-risk situations such as bilateral disease or unilateral recurrence after a prior failure. Overall success was 85.6% with the algorithm versus 64.2% without it. Review the clinical series on selective ADM use.
Matching support to the tissue problem
Surgical mesh offers a different type of reinforcement. GalaFLEX mesh may be discussed when the pocket needs structural support, especially in complex revision or reconstruction settings. The GalaFLEX mesh information can help patients understand why a surgeon might add mesh rather than rely only on the capsule and native tissues.
J-stitch techniques can help reshape or narrow a pocket when internal suturing is needed to correct implant position. They don't eliminate the need to address the capsule or exchange the implant when those steps are indicated. The material and technique should follow the tissue problem, not a predetermined package.
ADM isn't universally protective. Recurrence can still occur, and radiation history can predict implant loss and recurrence. ADM can also be associated with complications such as seroma or contracture in selected patients. The consultation should include the added operation, material-specific risks, cost considerations, and the possibility that further revision may still be necessary.
Perioperative Strategies to Reduce Recurrence Risk
A revision can fail even when the capsule is removed thoroughly. Durable planning addresses the patient's health, implant choice, pocket, contamination control, support materials, and follow-up as one connected process. Bring prior operative reports, implant records, imaging, and a clear description of when the breast began to change. Those details help identify why the first operation failed and which variables need to change.
Before the operation
The surgeon reviews medical conditions, medications, nicotine exposure, previous radiation, breast tissue quality, implant size, and the reason prior operations failed. Implant selection isn't a matter of choosing the same size again. A different size, profile, fill, or surface may fit the revised pocket and soft-tissue envelope better. In some cases, changing the pocket matters more than changing the implant.
Evidence about implant surfaces remains unsettled. An early comparative study found no significant recurrence difference between textured and nanotextured implants after revision. A 2025 revisional series involving polyurethane implants reported no recurrent contracture over an average five-year follow-up, but that limited, single-center finding does not prove that one surface prevents recurrence. Review the medication and implant-surface evidence.
During and after surgery
Intraoperative priorities include limiting tissue trauma, controlling bleeding, reducing implant handling, preparing the pocket accurately, and using irrigation according to the surgeon's protocol. Antibiotic irrigation may support contamination reduction, but it does not replace sterile technique, careful implant handling, or appropriate pocket design. Isolated capsulectomy may fail when the underlying pocket, implant position, or soft-tissue support remains unchanged.
After surgery, follow the specific instructions for drains, dressings, compression, massage, lifting, and exercise. Massage may be recommended in one plan and restricted in another, especially when ADM, mesh, or pocket sutures are used. The operation performed determines the aftercare.
Your part of recurrence prevention: Report unusual swelling, redness, drainage, fever, worsening pain, or a sudden shape change instead of managing those symptoms at home.
Follow-up appointments let the surgeon assess healing and implant position before unrestricted activity resumes. Radiation history may call for more cautious planning or additional support because irradiated tissues can heal and respond differently. A sound plan is individualized, documented, and candid about recurrence risk, including the possibility that another revision may eventually be needed.
Recovery Expectations and Long-Term Follow-Up
Recovery after revision depends on how much surgery is required. A limited release may feel different from a total capsulectomy with implant exchange, pocket conversion, and ADM or mesh support. Pain, tightness, swelling, bruising, temporary asymmetry, and altered sensation can occur during healing, but your surgeon should explain what's expected for your specific procedure rather than promise one universal timeline.
Early follow-up matters. Contact the surgical team promptly for increasing redness, drainage, fever, worsening rather than improving pain, sudden swelling, shortness of breath, or a rapid change in breast shape. These symptoms don't prove recurrence, but they warrant assessment because infection, fluid collection, bleeding, implant problems, and healing complications require different responses.
Recurrence requires surveillance
Revision can improve softness, comfort, and shape without guaranteeing that contracture will never return. In a 2024 study of implant-based breast reconstruction revision surgery, selective capsulotomies and partial capsulectomy were followed by a 19% recurrence rate, with average follow-up of 59 months, ranging from 13 to 114 months. Read the long-term revision study.
Radiation changed the risk profile in that study. Two of six radiated cases, or 33%, developed tertiary capsular contracture, compared with four of 26 non-radiated cases, or 15%. Those figures apply to that study population, not to every patient, but they show why a history of radiation must be part of the surgical strategy from the beginning.
Choose a revision surgeon who can explain not only what will be removed, but also why the implant may be exchanged, whether the pocket should change, and when ADM, GalaFLEX, or J-stitch support is justified. Dr. Thomas T. Jeneby at the Plastic and Cosmetic Center of South Texas evaluates capsular contracture and complex revision needs in the context of each patient's anatomy, prior surgery, medical history, and goals. General information can prepare you for the discussion, but only an examination can determine the appropriate treatment.
The Plastic and Cosmetic Center of South Texas offers evaluation and treatment planning for capsular contracture, including breast implant revision approaches that may involve capsulectomy, implant exchange, pocket change, mesh, or J-stitch techniques when appropriate. Visit Plastic and Cosmetic Center of South Texas to request a consultation with Dr. Thomas T. Jeneby in San Antonio and discuss your specific symptoms and revision options.
